A091902 (Soft Tissue Sarcoma) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to see how an experimental drug called nivolumab works in your body and against your cancer.

What is the Condition Being Studied?

Soft Tissue Sarcoma (Angiosarcoma)

Who Can Participate in the Study?

Adults ages 18 and older who have angiosarcoma.

Age Group
Adults

What is Involved?

We are enrolling people who have not been treated with a class of anticancer drugs called taxanes.

If you join this study, you will:
- Be randomly assigned (a fair 50/50 chance) to either Group 1 or Group 2
-- Group 1 will get treatment with a chemotherapy drug called paclitaxel and the study drug nivolumab
-- Group 2 will get treatment with paclitaxel alone

Study Details

Full Title
A MULTICENTER PHASE II TRIAL OF PACLITAXEL WITH AND WITHOUT NIVOLUMAB IN TAXANE NAÏVE, AND NIVOLUMAB AND CABOZANTINIB IN TAXANE PRETREATED SUBJECTS WITH ANGIOSARCOMA
Principal Investigator
Medical Oncologist
Protocol Number
IRB: PRO00107811
NCT: NCT04339738
Phase
Phase II
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698